Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
ZYNE

Overview Financials Analysis Smart Money

Zynerba Pharmaceuticals, Inc.

ZYNE · NASDAQ

Analyze with AI

Filings1

Total reported value$130.0

Manager	Shares	Value	Change
Kistler-Tiffany Companies, LLC	100	$130.0	0.0%

SymbolZYNE

Market Cap$70.1M

IPO Date2015-08-05

CEOArmando Anido MBA

Employees25

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

CountryUS

ExchangeNASDAQ Global Market

Crown ElectroKinetics Corp.

CRKN

$0.11

+115.69%

Aimei Health Technology Co., Ltd

AFJK

$52.23

+100.81%

Athira Pharma, Inc.

ATHA

$6.72

+62.52%

Sable Offshore Corp.

SOC

$8.25

+56.25%

Zeta Network Group

ZNB

$1.02

+55.73%

Peers

The Valens Company Inc.

VLNS · NASDAQ

$0.7612

+0.00%

Chicago Atlantic BDC, Inc.

LIEN · NASDAQ

$10.86

-0.64%

Quince Therapeutics, Inc.

QNCX · NASDAQ

$3.48

-6.45%

DURECT Corporation

DRRX · NASDAQ

$1.91

-1.04%

Akoya Biosciences, Inc.

AKYA · NASDAQ

$1.29

-5.15%

Zomedica Corp.

ZOM · AMEX

$0.0973

-0.21%

Bonk, Inc.

BNKK · NASDAQ

$3.79

+5.87%

IGM Biosciences, Inc.

IGMS · NASDAQ

$1.27

+0.00%

MindWalk Holdings Corp.

HYFT · NASDAQ

$1.64

-7.34%

Surface Oncology, Inc.

SURF · NASDAQ

$1.07

-0.93%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.